-AD-
-AD-
HomeNewsSynternet Adds Injective Network to Its Multi-Chain Data Layer

Synternet Adds Injective Network to Its Multi-Chain Data Layer

- Advertisement -

Gibraltar, Gibraltar, May 1st, 2024, Chainwire

Blockchain infrastructure provider Synternet has announced that it has added Injective’s layer1 network to its flagship Data Layer. The integration will allow developers to access reliable onchain data delivered from the Cosmos chain.

The integration of Injective has been implemented with the support of testnet validator Stakin. By leveraging Stakin’s enterprise-grade infrastructure, Synternet makes all Injective’s Layer 1 network data streams, including subsets such as  .mempool and .proposed-block, available on its Data Layer Portal.

The addition of Injective data streams to Synternet’s Data Layer will furnish developers with reliable data that can be used to power financial applications. Accurate pricing of Injective assets can be queried, supporting the creation of dapps such as DEXes and trading bots.

Synternet CTO Jonas Simanavicius said: “In today’s era of rapidly evolving DeFi markets, real-time data isn’t just an advantage: it’s a necessity. With Injective’s blockchain data streams now live on the Data Layer Portal, we’re empowering developers and market makers with the precision and speed needed to innovate and stay ahead.”

The ability for proposed block and mempool activities to be streamed will give market makers vital real-time insights into the latest network activity on Injective. The low-latency streams Data Layer can access via Stakin are integral to revealing proposed block transactions. This provision will empower market makers to accurately anticipate price movements and capitalize on this information by executing trades.

The integration of real-time Injective data streams with the support of Stakin signals Synternet’s intention of expanding its presence within the Cosmos ecosystem. This will provide a strong foundation for the launch of Synternet’s native blockchain which is poised to debut on Cosmos in Q2.

About Injective

Injective is a lightning-fast interoperable layer one blockchain optimized for building the premier Web3 finance applications. Injective provides developers with powerful plug-and-play modules for creating unmatched dApps. INJ is the native asset that powers Injective and its rapidly growing ecosystem. Injective is incubated by Binance and is backed by prominent investors such as Jump Crypto, Pantera and Mark Cuban.

Learn more about the latest from Injective on Twitter/X or Injective | The blockchain built for finance

About Synternet

Synternet is a blockchain that powers modular, interoperable data infrastructure across all major chains. At its core lies the Data Layer, a protocol serving as the customizable execution layer between blockchains. Its AEAs (Autonomous Economic Agents) empower developers to build composable, use-case-specific applications that can execute on any data from any chain. Synternet has secured the backing of prominent Web3 investors, including Polygon Ventures, CMCC, Faculty Group, Moonrock Capital, HV Capital, and many others.

To learn more about Synternet: Website | Twitter | Telegram | Docs

Contact

Emilis Klybas
emilis@syntropynet.com

ETHNews: This publication is sponsored. ETHNews does not endorse and is not responsible for or liable for any content, accuracy, quality, advertising, products, or other materials on this page. Readers should conduct their own research before taking any actions related to the company. ETHNews is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods, or services mentioned in the press release.
This article is provided for informational purposes only and is not intended as investment advice. The content does not constitute a recommendation to buy, sell, or hold any securities or financial instruments. Readers should conduct their own research and consult with financial advisors before making investment decisions. The information presented may not be current and could become outdated.
By accessing and reading this article, you acknowledge and agree to the above disclosure and disclaimer.
RELATED ARTICLES

LATEST ARTICLES